Oncolysis of human gastric cancers by an E1B 55 kDa-deleted YKL-1 adenovirus

Cancer Letters

Volumn 185, Issue 2, 2002, Pages 225-233

  Lee, Boyoung ^a   Choi, Jene ^a   Kim, Jaesung ^a   Kim, Joo Hang ^a   Joo, Chul Hyun ^a   Cho, Young Keol ^a   Kim, Yoo Kyum ^a   Lee, Heuiran ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Gastric cancer; Oncolysis; p53; YKL 1

Indexed keywords

PROTEIN P53; RECOMBINANT DNA; UNCLASSIFIED DRUG; YKL 1; CAMPTOTHECIN; E1B PROTEIN; TUMOR PROTEIN; VIRUS DNA;

ARTICLE; CANCER CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOLYSIS; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; VIRUS REPLICATION; ADENOCARCINOMA; BINDING SITE; CELL CULTURE; CYTOPATHOGENIC EFFECT; GENE DELETION; GENE VECTOR; GENETICS; HUMAN ADENOVIRUS; METABOLISM; MISSENSE MUTATION; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN BINDING; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOVIRUS E1B PROTEINS; ADENOVIRUSES, HUMAN; BINDING SITES; CAMPTOTHECIN; CYTOPATHOGENIC EFFECT, VIRAL; DNA, RECOMBINANT; DNA, VIRAL; GENE DELETION; GENES, P53; GENETIC VECTORS; HUMAN; MUTATION, MISSENSE; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN BINDING; PROTEIN P53; STOMACH NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; VIRUS REPLICATION; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 0037191514     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00279-3     Document Type: Article

References (32)

1. Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo
2. Cancer of the stomach: A patient care study by the American College of Surgeons
3. P53 mutations in human cancer
4. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck
5. Complete sequencing of the p53 gene provides information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
6. Molecular biology of cancer: Oncogenes
7. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
8. P53 mutation and MDM2 amplification in human soft tissue sarcomas
9. MDM2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations
10. Implication of the p53 tumor-suppressor gene in clinical oncology
11. An adenovirus mutant that replicates selectively in p53 deficient human tumor cells
12. ONYX 015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
13. ONYX-015: Clinical data are encouraging
14. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer
15. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
16. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein
17. Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
18. Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: Correlation with p53 functional status
19. P53-dependent cell death/apoptosis is required for a productive adenovirus infection
20. P53 status does not determine outcome of E1B 55 kilodalton mutant adenovirus lytic infection
21. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells
22. P53-independent and -dependent requirements for E1B 55K in adenovirus type 5 replication
23. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: The importance of the adenoviral E1B-55kD gene
24. The replicative capacities of large E1B-null group A and group C adenovirus are independent of host cell p53 status
25. Characteristics of cell lines established from human gastric carcinoma
26. Construction and propagation of human adenovirus vectors
27. Functional p53 protein in human papillomavirus-positive cancer cells
28. P53 function and dysfunction
29. ARF Modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53
30. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
31. Characteristics of a human cell line transformed by DNA from human adenovirus type 5